Medical News

RSS

Saturday night vote set on house health reform

The Washington Post reports: "Democratic whips worked their rank and file, while House leaders tried to secure a momentum-building endorsement from the AARP, the nation's largest association of people over 50. President Obama, meanwhile, laid plans to visit Capitol Hill on Thursday or Friday to address House Democrats in a final push for his signature domestic initiative.

5 Nov 2009

Environmental Tectonics bags two new contracts worth $700,000 from previous customers

Environmental Tectonics Corporation's Sterilization Systems Group (SSG), a division of ETC's Control Systems Group (CSG), today announced the award of two new contracts for large, industrial sized sterilization systems from previous customers. The combined contract values exceed $700,000.

5 Nov 2009

GOP lawmakers seek to explore health reform's impact on FEHBP

Government Executive.com: "Sixteen Republican representatives wrote to Oversight and Government Reform Committee Chairman Edolphus Towns, D-N.Y., to demand that he schedule hearings on reform proposals' potential impact on the Federal Employees Health Benefits Program."

5 Nov 2009

Newborns' cries already bear the mark of their parents' language, reveals new study

From their very first days, newborns' cries already bear the mark of the language their parents speak, reveals a new study published online on November 5th in Current Biology, a Cell Press publication. The findings suggest that infants begin picking up elements of what will be their first language in the womb, and certainly long before their first babble or coo.

5 Nov 2009

Abraxis BioScience reports $96.6 million net revenues for third quarter of 2009

Abraxis BioScience, Inc., a fully integrated biotechnology company, today reported unaudited financial results for the third quarter ending September 30, 2009.

5 Nov 2009

Also in global health news: Kenya child mortality; DRC rape; Cape Verde dengue outbreak; Guatemala malnutrition; East Africa flooding

"The most current data from the Kenya National Bureau of Statistics under the Demographic and Health Survey (DHS) launched on Wednesday shows mortality among children under five years stands at 7.4 percent, while that of infants is at 5.2 percent," Business Daily reports.

5 Nov 2009

Democrats weigh impact of election results on health reform

While some Democrats seem rattled by election results this week, others say the GOP victories in two races for governor won't change their approach to health overhaul legislation.

5 Nov 2009

Cadence Pharmaceuticals reports net loss of $11.4 million for three months ended September 30, 2009

Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today reported financial results for the three and nine months ended September 30, 2009.

5 Nov 2009

CBO: GOP health bill would cut deficit somewhat, do little to expand coverage

"The Congressional Budget Office said Wednesday that the alternative health care bill proposed by House Republicans would have little impact in extending health benefits to the roughly 30 million uninsured Americans, but would reduce average insurance premium costs for people who have coverage," The New York Times reports.

5 Nov 2009

AMA announces support for concurrent passage of health system reform bills

The American Medical Association (AMA) today announced support for concurrent passage of H.R. 3962 and H.R. 3961, U.S. House of Representatives health system reform bills.

5 Nov 2009

TPG Capital, CPP Investment Board to acquire IMS Health

IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced that it has entered into a definitive agreement to be acquired by investment funds managed by TPG Capital (“TPG”) and the CPP Investment Board (“CPPIB”) in a transaction with a total value of $5.2 billion, including the assumption of debt.

5 Nov 2009

AARP, key retirees' lobby, to endorse Democrats' health bill

AARP, the influential retirees' lobby, is expected to endorse House Democrats' plan to overhaul the health system today, the Associated Press reports, citing unnamed officials. "Backing the 10-year, $1.2 trillion House bill is a tricky move for AARP.

5 Nov 2009

Climate change is biggest global health threat to children, report says

According to a report (.pdf) by Save the Children, climate change is the biggest global health threat to children in the 21st century, the Hindu reports. Save the Children says that climate change will "exacerbate the leading causes of death among children, including diarrhoea, malnutrition and malaria. Diarrhoea, which kills one million children every year, is set to increase by 10 percent by 2020.

5 Nov 2009

Health overhaul outlook: Could delays jeopardize the reform effort?

Kaiser Health News staff writers Mary Agnes Carey and Eric Pianin report on whether current timeline slips may or may not undermine health reform's chances. "Passing a health care overhaul bill might be one of the hardest things Congress has ever attempted. But waiting until next year might jeopardize a top priority for President Barack Obama and Democrats in Congress.

5 Nov 2009

Re-classification of cannabis will have minimal impact on incidence of psychosis says study

The research follows last year’s decision by the UK government to reclassify the drug from class C to class B, partly out of concerns that cannabis, especially the more potent varieties, may increase the risk of schizophrenia in young people. However, the evidence for the relationship between cannabis and schizophrenia or psychosis remains controversial.

5 Nov 2009

Nanoparticles may cause DNA damage across a cellular barrier

Scientists have shown in the laboratory that metal nanoparticles damaged the DNA in cells on the other side of a cellular barrier. The nanoparticles did not cause the damage by passing through the barrier, but generated signalling molecules within the barrier cells that were then transmitted to cause damage in cells the other side of the barrier.

5 Nov 2009

FDA grants Abraxis BioScience orphan drug designation for ABRAXANE

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced that the Office of Orphan Products Development of the Food and Drug Administration (FDA) has granted orphan drug designation to the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the treatment of pancreatic cancer as well as stage IIB-IV melanoma.

5 Nov 2009